|
|
Gynecologic Cancer Studies Currently Recruiting Participants at SimmonsCooper Cancer Research Center at Southern Illinois University
| Protocol Title |
Study # |
Study Group |
Cervical
| A Phase III, Randomized Trial of Weekly Cisplatin and Radiation Versus Cisplatin and Tirapazamine and Radiation in Stage IB2, IIA, IIIB and IVA Cervical Carcinoma Limited to the Pelvis |
GOG 0219 |
CICCOP |
| A Phase II Evaluation of Cetuximab (Erbitux®, C225, NSC# 714692) in the Treatment of Persistent or Recurrent Squamous or Non-Squamous Cell Carcinoma of the Cervix |
GOG 0227E |
CICCOP |
| A Randomized Phase III Trial of Cisplatin Plus Paclitaxel With and Without NCI-Supplied Bevacizumab (NSC #704865, IND #7921) Versus the Non-Platinum Doublet, Topotecan Plus Paclitaxel, With and Without NCI-Supplied Bevacizumab, In Stage IVB, Recurrent or Persistent Carcinoma of the Cervix |
GOG 0240 |
CICCOP |
Ovarian
| A Phase 3, Randomized, Open-Label Study of Neratinib Versus Lapitinib Plus Capecitabine for the Treatment fo ErbB-2-Positive Locally Advance or Metastatic Breast Cancer |
09-062 |
SCCI |
| A Randomized Phase III Trial of Maintenance Chemotherapy Comparing 12 Monthly Cycles of Single Agent Paclitaxel or Xyotax (CT-2103) (IND# 70177), Versus No Treatment Until Documented Relapse in Women With Advanced Ovarian or Primary Peritoneal Cancer Who Achieve a Complete Clinical Response to Primary Platinum/Taxane Chemotherapy |
GOG 0212 |
CICCOP |
| A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel Alone or in Combination With Bevacizumab (NSC #704865, IND #7921) Followed by Bevacizumab and Secondary Cytoreduction Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer |
GOG 0213 |
CICCOP |
| Nurse-Delivered Write Symptoms vs Self-Directed Write Symptoms vs Care as usual for optimal symptom management for women with Recurrent Ovarian, Fallopian Tube or Primary Peritoneal cancer |
GOG 0259 |
CICCOP |
| A Phase III Clinical Trial of Bevacizumab With IV Versus IP Chemotherapy in Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma NCISupplied Agent(s): Bevacizumab (NSC #704865, IND #7921) |
GOG 0252 |
CICCOP |
| |
|
|
Uterine
| A Phase III Trial of Pelvic Radiation Therapy Versus Vaginal Cuff Brachytherapy Followed By Paclitaxel/Carboplatin Chemotherapy in Patients With High Risk, Early Stage Endometrial Carcinoma |
GOG 0249 |
CICCOP |
| A Phase II Evaluation of AZD6244 (NSC# 748727, CTEP IND #77782) in Women with Recurrent or Persistent Endometrial Carcinoma |
GOG 0229H |
CICCOP |
| A Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Ifosfamide Plus Paclitaxel in Chemotherapy-Naive Patients With Newly Diagnosed Stage I-IV, Persistent or Recurrent Carcinosarcoma (Mixed Mesodermal Tumors) of the Uterus |
GOG 0261 |
CICCOP |
| A Randomized Phase III Trial of Cisplatin and Tumor Volume Directed Irradiation Followed by Carboplatin and Paclitaxel vs. Carboplatin and Paclitaxel for Optimally Debulked, Advanced Endometrial Carcinoma |
GOG 0258 |
CICCOP |
Vulvar
| A Phase II Trial of Radiation Therapy and Weekly Cisplatin Chemotherapy for the Treatment of Locally-Advanced Squamous Cell Carcinoma of the Vulva |
GOG 0205 |
CICCOP |
Cancer Care/Symptom Management
| A Phase II Randomized Study of the Effect of Zoledronic Acid Versus Observation on Bone Mineral Density of the Lumbar Spine in Women Who Elect to Undergo Surgery That Results in Removal of Both Ovaries |
GOG 0215 |
CICCOP |
Although our objective is to provide an updated listing of available clinical trials please note that a listing here does not guarantee that a trial is open or available to any specific patient and that there may be additional trials available that are not listed. Complete information is only available from a treating physician.
Contact Information:
SimmonsCooper Cancer Institute Clinical Trials Office
Mail Code 9677 Fax (217) 545-6823
- Kathy Robinson, PhD, Director of Clinical Trials
(217) 545-1946
- Susan Klug, RN, OCN
(217) 545-7929
- Jennifer Bekker RN, BSN
(217) 545-2219
-
SIU COG
- Carol Peterson, RN, CCRP (217) 545-7377
SIU IM
- Amanda Fogleman, B.A. (217) 545-0592
- Cathy Naritoku, M.S., RD (217)545-8078
SIU Thoracic
- Theresa Boley, RN, MSN, APN/FNP-BC, CCRP (217) 545-5000
-
- Cathy Leslie, RN (217) 545-8184
- Cheryl Ogden, RN, CCRC (217) 545-7474
-
RTOG: Radiation Therapy Oncology Group:
- Diana Weyhenmeyer, RN, M.A., OCN (217) 544-6464 ext. 45591
CICCOP: Central Illinois Community Clinical Oncology Program
Memorial Medical Center CICCOP Research Contacts:
Treatment/Cancer Control:
- Holly Thomas (217) 788-4178
- Stephanie Allbritton (217) 788-3544
- Brooke Trickey (217) 217-788-3560
- Karen Graber (217) 588-2961
- Chrissy Tucker (217) 788-4444
|
 |
|
